Page last updated: 2024-08-23

mifepristone and Affective Disorders

mifepristone has been researched along with Affective Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbero, JD; Bioque, M; Cobo, J; García-Rizo, C; González-Rodríguez, A; Huerta-Ramos, E; Labad, J; Monreal, JA; Soria, V; Tost, M; Usall, J1
Davies, H; Fang, M; Hu, Z; Sun, Y1
Baier, H; Ingraham, HA; Meijsing, SH; Muto, A; Schaaf, MJ; Schoonheim, PJ; Strasser, D; Yamamoto, KR; Ziv, L1
Creinin, MD; Hanusa, BH; Rothschild, AJ; Sit, D; Wisner, KL1
Barber, DJ; Griffiths, MR; Haynes, LE; Hyde, RE; Mitchell, IJ1

Reviews

2 review(s) available for mifepristone and Affective Disorders

ArticleYear
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
    Psychoneuroendocrinology, 2018, Volume: 93

    Topics: Affective Disorders, Psychotic; Bipolar Disorder; Cognition Disorders; Cognitive Dysfunction; Depressive Disorder, Major; Female; Gonadal Steroid Hormones; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Mifepristone; Mood Disorders; Pituitary-Adrenal System; Pregnenolone; Raloxifene Hydrochloride; Schizophrenia

2018
Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:3

    Topics: Abortifacient Agents, Steroidal; Antidepressive Agents; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Synthetic; Cushing Syndrome; Endometriosis; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Leiomyoma; Male; Mifepristone; Mood Disorders; Receptors, Glucocorticoid; Receptors, Progesterone

2014

Other Studies

3 other study(ies) available for mifepristone and Affective Disorders

ArticleYear
An affective disorder in zebrafish with mutation of the glucocorticoid receptor.
    Molecular psychiatry, 2013, Volume: 18, Issue:6

    Topics: Analysis of Variance; Animals; Animals, Genetically Modified; Anti-Anxiety Agents; Arginine; Brain; Cell Line, Transformed; Chlorocebus aethiops; Corticotropin-Releasing Hormone; Cysteine; Diazepam; Disease Models, Animal; Escape Reaction; Exploratory Behavior; Fluoxetine; Freezing Reaction, Cataleptic; Hormone Antagonists; Humans; Hydrocortisone; Interpersonal Relations; Mifepristone; Mood Disorders; Mutation; Psychomotor Agitation; Radioimmunoassay; Receptors, Glucocorticoid; Serotonin; Transfection; Zebrafish

2013
Psychiatric outcomes following medical and surgical abortion.
    Human reproduction (Oxford, England), 2007, Volume: 22, Issue:3

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Adolescent; Adult; Antidepressive Agents; Depression; Female; Humans; Hydrocortisone; Mifepristone; Mood Disorders; Pregnancy; Saliva; Vacuum Curettage

2007
Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders.
    Neuroscience, 2001, Volume: 104, Issue:1

    Topics: Animals; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Apoptosis; Avian Proteins; Basigin; Behavior, Animal; Blood Proteins; Dexamethasone; Dose-Response Relationship, Drug; Glucocorticoids; Hippocampus; Hormone Antagonists; Immunohistochemistry; Male; Membrane Glycoproteins; Microtubule-Associated Proteins; Mifepristone; Mood Disorders; Neostriatum; Nerve Degeneration; Rats; Rats, Sprague-Dawley; Septal Nuclei

2001